NCT02885675

Brief Summary

To evaluate the correlation between the value of miRNA related to ARDS and vascular endothelial cell and ARDS severity, vascular endothelial cell damaging degree，mortality in patients with ARDS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 25, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 31, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

August 31, 2016

Status Verified

August 1, 2016

Enrollment Period

11 months

First QC Date

August 25, 2016

Last Update Submit

August 30, 2016

Conditions

ARDS

Outcome Measures

Primary Outcomes (1)

  • mortality

    28-day

Study Arms (2)

ARDS

Other: blood sampling

Healthy control

Other: blood sampling

Interventions

blood samplingOTHER

sample no more than 3ml

ARDSHealthy control

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

20 healthy controls and 60 patients diagnose as ARDS in ICU were included in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhong-Da hospital

Nanjing, Jiangsu, 210009, China

RECRUITING

MeSH Terms

Interventions

Blood Specimen Collection

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Central Study Contacts

Hunag Yingzi, doctor

CONTACT

+8613951693278yz_huang@126.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Zhongda Hospital

Study Record Dates

First Submitted

August 25, 2016

First Posted

August 31, 2016

Study Start

March 1, 2016

Primary Completion

February 1, 2017

Study Completion

February 1, 2017

Last Updated

August 31, 2016

Record last verified: 2016-08

Locations

CN(1)